Novo Nordisk Says Danish Studies Didn't Show Semaglutide's Link With Eye Disease

MT Newswires11:35 ET

Lennox International to Replace Catalent in S&P 500; BILL Holdings to Join S&P MidCap 400

MT Newswires05:35 ET

The prospects of European Medical Care stocks are complex, with USA policies and new drug trial results being the key factors.

After falling from a high position in the last few months of 2024, European Medical Care stocks face the risks of US politics and the results of high-risk new drug trials in the new year.

Zhitong Finance01:48 ET

Healthcare Stocks Had a Dismal Year. Therein Lies -2-

Barron's00:05 ET

10 Health Care Stocks With Whale Alerts In Today's Session

Benzinga12:35 ET

Vikings Therapeutics Plummets 11% As Merck Licenses a Weight-Loss Pill From A Chinese Drugmaker

Barron's12:17 ET